Journal article

Iatrogenic Creutzfeldt-Jakob disease at the millennium

P Brown, M Preece, JP Brandel, T Sato, L McShane, I Zerr, A Fletcher, RG Will, M Pocchiari, NR Cashman, JH D'Aignaux, L Cervenáková, J Fradkin, LB Schonberger, SJ Collins

Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2000

Abstract

The causes and geographic distribution of 267 cases of iatrogenic Creutzfeldt-Jakob disease (CJD) are here updated at the millennium. Small numbers of still-occurring cases result from disease onsets after longer and longer incubation periods following infection by cadaveric human growth hormone or dura mater grafts manufactured and distributed before the mid-1980s. The proportion of recipients acquiring CJD from growth hormone varies from 0.3 to 4.4% in different countries, and acquisition from dura mater varies between 0.02 and 0.05% in Japan (where most cases occurred). Incubation periods can extend up to 30 years, and cerebellar onsets predominate in both hormone and graft recipients (in..

View full abstract

University of Melbourne Researchers